TransMedics Net Working Capital from 2010 to 2025

TMDX Stock  USD 66.95  1.42  2.17%   
TransMedics Net Working Capital yearly trend continues to be fairly stable with very little volatility. Net Working Capital is likely to outpace its year average in 2025. During the period from 2010 to 2025, TransMedics Net Working Capital regression line of annual values had r-squared of  0.66 and arithmetic mean of  142,518,119. View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
524.1 M
Current Value
550.3 M
Quarterly Volatility
191.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 13 M, Selling General Administrative of 144.4 M or Research Development of 76.4 M, as well as many indicators such as Price To Sales Ratio of 11.6, Dividend Yield of 0.0 or PTB Ratio of 17.68. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.
  
Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of TransMedics Group over the last few years. It is TransMedics' Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

TransMedics Net Working Capital Regression Statistics

Arithmetic Mean142,518,119
Geometric Mean62,850,517
Coefficient Of Variation134.55
Mean Deviation148,580,053
Median23,137,000
Standard Deviation191,757,069
Sample Variance36770.8T
Range528M
R-Value0.81
Mean Square Error13340.7T
R-Squared0.66
Significance0.0001
Slope32,755,433
Total Sum of Squares551561.6T

TransMedics Net Working Capital History

2025550.3 M
2024524.1 M
2023455.7 M
2022228.6 M
202195.5 M
2020134.9 M
201983.9 M

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Net Working Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital524.1 M550.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.